Inogen (INGN) Income towards Parent Company (2013 - 2026)
Inogen's (INGN) quarterly Income towards Parent Company came in at -$3.8 million in Q2 2026, up 7.27% year-over-year from -$3.6 million in Q2 2025, and up 53.75% quarter-over-quarter from -$8.3 million in Q1 2026.
Analysis
Inogen (INGN) Income towards Parent Company (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Income towards Parent Company for 14 consecutive years, with -$3.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 7.27% year-over-year to -$3.8 million in Q2 2026; TTM through Jun 2026 was -$20.3 million, a 21.99% increase from a year earlier, with the FY2025 full-year figure at -$18.5 million, up 48.53% from the prior year.
- Income towards Parent Company was -$3.8 million for Q2 2026 at Inogen, up from -$8.3 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at -$2.8 million in Q4 2025 and troughed at -$57.8 million in Q4 2022.
- A 5-year average of -$14.1 million and a median of -$8.9 million in 2022 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company sank 1841.8% in 2022 and surged 86.96% in 2024, its largest moves.
- Over 5 years, Income towards Parent Company stood at -$57.8 million in 2022, then surged by 53.59% to -$26.8 million in 2023, then soared by 63.6% to -$9.8 million in 2024, then jumped by 70.79% to -$2.8 million in 2025, then slumped by 35.09% to -$3.8 million in 2026.
- The last three Income towards Parent Company figures came in at -$3.8 million (Q2 2026), -$8.3 million (Q1 2026), and -$2.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn |
| 10 | Inogen | 142.66 Mn | 37.12 Mn | 43.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.85 Mn |
| Mar 31, 2026 | -8.32 Mn |
| Dec 31, 2025 | -2.85 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -9.76 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -14.58 Mn |
| Dec 31, 2023 | -26.81 Mn |
| Sep 30, 2023 | -45.72 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | -57.76 Mn |
| Sep 30, 2022 | -9.51 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -22.88 Mn |
| Sep 30, 2021 | 12.17 Mn |